Mental Health

More Coffee Could Lower Skin Cancer Risk

By Staff Reporter | Update Date: Jul 02, 2012 02:51 PM EDT

According to a study published in Cancer Research, a journal of the American Association for Cancer Research, increasing the number of cups of caffeinated coffee you drink could lower your risk of developing the most common form of skin cancer, basal cell carcinoma.

 "Our data indicate that the more caffeinated coffee you consume, the lower your risk of developing basal cell carcinoma," said Jiali Han, Ph.D., associate professor at Brigham and Women's Hospital, Harvard Medical School in Boston and Harvard School of Public Health.

However, Han said be cautious about increasing the amount of coffee you consume daily.

"I would not recommend increasing your coffee intake based on these data alone," said Han. "However, our results add basal cell carcinoma to a list of conditions for which risk is decreased with increasing coffee consumption. This list includes conditions with serious negative health consequences such as type 2 diabetes and Parkinson's disease."

Basal cell carcinoma is the form of skin cancer most notably associated with the United States. Even though it is slow-growing, it causes considerable morbidity and places a burden on health care systems.

"Given the large number of newly diagnosed cases, daily dietary changes having any protective effect may have an impact on public health," said Han.

Researchers observed over 100,000 participants and nearly 23,000 developed the skin cancer.

"These results really suggest that it is the caffeine in coffee that is responsible for the decreased risk of basal cell carcinoma associated with increasing coffee consumption," said Han. "This would be consistent with published mouse data, which indicate caffeine can block skin tumor formation. However, more studies in different population cohorts and additional mechanistic studies will be needed before we can say this definitively."

© 2024 Counsel & Heal All rights reserved. Do not reproduce without permission.

Join the Conversation

Real Time Analytics